AIRLINK 74.85 Increased By ▲ 0.56 (0.75%)
BOP 4.98 Increased By ▲ 0.03 (0.61%)
CNERGY 4.49 Increased By ▲ 0.12 (2.75%)
DFML 40.00 Increased By ▲ 1.20 (3.09%)
DGKC 86.35 Increased By ▲ 1.53 (1.8%)
FCCL 21.36 Increased By ▲ 0.15 (0.71%)
FFBL 33.85 Decreased By ▼ -0.27 (-0.79%)
FFL 9.72 Increased By ▲ 0.02 (0.21%)
GGL 10.45 Increased By ▲ 0.03 (0.29%)
HBL 112.74 Decreased By ▼ -0.26 (-0.23%)
HUBC 137.44 Increased By ▲ 1.24 (0.91%)
HUMNL 11.42 Decreased By ▼ -0.48 (-4.03%)
KEL 5.28 Increased By ▲ 0.57 (12.1%)
KOSM 4.63 Increased By ▲ 0.19 (4.28%)
MLCF 37.80 Increased By ▲ 0.15 (0.4%)
OGDC 139.50 Increased By ▲ 3.30 (2.42%)
PAEL 25.61 Increased By ▲ 0.51 (2.03%)
PIAA 20.68 Increased By ▲ 1.44 (7.48%)
PIBTL 6.80 Increased By ▲ 0.09 (1.34%)
PPL 122.20 Increased By ▲ 0.10 (0.08%)
PRL 26.58 Decreased By ▼ -0.07 (-0.26%)
PTC 14.05 Increased By ▲ 0.12 (0.86%)
SEARL 58.98 Increased By ▲ 1.76 (3.08%)
SNGP 68.95 Increased By ▲ 1.35 (2%)
SSGC 10.30 Increased By ▲ 0.05 (0.49%)
TELE 8.38 Decreased By ▼ -0.02 (-0.24%)
TPLP 11.06 Decreased By ▼ -0.07 (-0.63%)
TRG 64.19 Increased By ▲ 1.38 (2.2%)
UNITY 26.55 Increased By ▲ 0.05 (0.19%)
WTL 1.45 Increased By ▲ 0.10 (7.41%)
BR100 7,841 Increased By 30.9 (0.4%)
BR30 25,465 Increased By 315.4 (1.25%)
KSE100 75,114 Increased By 157.8 (0.21%)
KSE30 24,114 Increased By 30.8 (0.13%)
Markets

S&P 500 flat as vaccine bets offset surging coronavirus cases; Boeing rises

  • Boeing surges on 737 MAX jet approval.
  • Pfizer gains on improved final vaccine trial data.
  • Lowe's slides after forecast disappoints.
  • Target, TJX rise as results beat.
  • Indexes: Dow up 0.2%, S&P flat, Nasdaq down 0.3%.
Published November 18, 2020

The S&P 500 was little changed on Wednesday as investors weighed near-term economic pain from surging coronavirus cases against growing optimism that a working vaccine was near, while the Dow was boosted by a rise in shares of Boeing.

The planemaker advanced 3.2% after getting US approval to fly its 737 MAX jet again after a 20-month grounding following two fatal crashes.

The news also lifted shares of airlines. American Airlines gained 3.6% and Southwest Airlines added 2.1% as the carriers laid out plans to fly the aircraft again.

Pfizer Inc said it would apply for emergency US authorization of its COVID-19 vaccine within days and disclosed final results from a late-stage trial that showed it was 95% effective. The drugmaker's shares rose 3%.

The announcement comes after Moderna Inc on Monday released preliminary data for its COVID-19 vaccine, showing similar effectiveness.

Meanwhile, the number of reported global daily deaths from the coronavirus stood at its highest ever on Tuesday, as the virus's global epicenter the United States entered winter.

"The current market narrative seems to encompass a tug-of-war between good news on the vaccine front, juxtaposed against increasing new cases of COVID," said Art Hogan, chief market strategist at National Securities in New York.

At 09:58 a.m. ET, the Dow Jones Industrial Average rose 69.04 points, or 0.23%, to 29,852.39, the S&P 500 fell 1.77 points or 0.05% to 3,607.76. The Nasdaq composite lost 41.47 points, or 0.35% to 11,857.87.

Target Corp rose 2.3% after the big-box retailer blew past expectations for quarterly profit and sales, as its quick delivery services boosted online shopping.

Discount store operator TJX Companies Inc rose about 3% after topping quarterly sales estimates.

"With earnings announcements coming in better than expected from the retail space and the positive news on Boeing, it should drive interest in cyclicals," said Robert Pavlik, senior portfolio manager at Dakota Wealth, New York.

S&P sectors sensitive to economic growth, such as financials , industrials, materials and energy , led the gainers.

The benchmark S&P 500 and the blue-chip Dow retreated from all-time highs on Tuesday as glum US retail sales data, as well as the specter of fresh restrictions dampened demand for risky assets.

Lowe's Cos Inc tumbled 5% as the home improvement chain forecast holiday-quarter earnings largely below analysts' estimates.

Advancing issues outnumbered decliners on the NYSE by a 1.9-to-1 ratio and by a 1.7-to-1 ratio on the Nasdaq.

The S&P 500 posted 12 new 52-week highs and no new low, while the Nasdaq Composite recorded 130 new highs and five new lows.

Comments

Comments are closed.